Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity ; volume:14 ; number:1 ; day:30 ; month:4 ; year:2014 ; pages:1-13 ; date:12.2014
BMC cancer ; 14, Heft 1 (30.4.2014), 1-13, 12.2014
- Creator
-
Cortes-Dericks, Lourdes
- Contributor
-
Froment, Laurène
Boesch, Ruben
Schmid, Ralph Alexander
Karoubi, Golnaz
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-304
- URN
-
urn:nbn:de:1111-2016030412590
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Cortes-Dericks, Lourdes
- Froment, Laurène
- Boesch, Ruben
- Schmid, Ralph Alexander
- Karoubi, Golnaz
- SpringerLink (Online service)
Other Objects (12)
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment
Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
Molecular biological analysis of malignant pleural mesothelioma
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment
Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
Molecular biological analysis of malignant pleural mesothelioma
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells
Genomic Landscape of Pleural Mesothelioma and Therapeutic Aftermaths
Proteasome stress sensitizes malignant pleural mesothelioma cells to bortezomib-induced apoptosis
CD44 and its ligand hyaluronan as potential biomarkers in malignant pleural mesothelioma: evidence and perspectives
CK2α, over-expressed in human malignant pleural mesothelioma, regulates the Hedgehog signaling pathway in mesothelioma cells
Differential regulation of the sphere formation and maintenance of cancer-initiating cells of malignant mesothelioma via CD44 and ALK4 signaling pathways
ADAM10 mediates malignant pleural mesothelioma invasiveness
Early detection of malignant pleural mesothelioma
KRAS signaling in malignant pleural mesothelioma
Chemotherapy increases CDA expression and sensitizes malignant pleural mesothelioma cells to capecitabine treatment
Characterization and drug sensitivity profiling of primary malignant mesothelioma cells from pleural effusions
Molecular biological analysis of malignant pleural mesothelioma
Treatment of malignant pleural mesothelioma by fibroblast activation protein-specific re-directed T cells